BioSpace News Archive

Sleeping aids are medicines and medical devices that are solutions to an individual’s sleeping disorder. Seeping aids ensure the treatment and diagnosis for sleep disturbances and disorders.

Reperfusion injury is referred to as the tissue damage caused due to absence of blood supply or lack of oxygen such as damage to brain after stroke or heart post episodes of ischemia.

Female sterilization procedure is a permanent way of preventing women from conceiving and acts as a form of birth control and is the most commonly used family planning method used across the globe.

The Fact.MR survey on cancer immunotherapy market offers detailed analysis on the key growth drivers and trends affecting demand in the market.

The assisted reproductive technology market survey offers comprehensive insights into factors impacting the overall growth trajectory.

Crescendo Biologics Ltd, a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, announces that senior members of the executive team will be participating at the following events.

Mindset Pharma Inc. announced that its first lead clinical candidate, MSP-1014, a differentiated next-generation psilocybin drug candidate from its Family 1 of novel, patent-pending psychedelic compounds, has further demonstrated superior efficacy and an improved safety profile in head-to-head pre-clinical comparisons to psilocybin.

Adagene Inc. today announced that its board of directors has authorized a share repurchase program under which, Adagene may repurchase up to US$20 million of its ordinary shares in the form of American depositary shares.

Arch Therapeutics, Inc. (OTCQB: ARTH) (“ Arch ” or the “ Company ”), developer of novel self-assembling wound care and biosurgical devices, today announced that it will present at the upcoming Ladenburg Thalmann 2021 Healthcare Conference, which shall be held July 13-14, 2021.

Jounce Therapeutics, Inc. today announced that Dmitri Wiederschain, Ph.D., Chief Scientific Officer will participate in a panel discussion at the William Blair’s Biotech Focus Conference taking place virtually on Wednesday, July 14, 2021 at 4:20 PM ET.